Candida norvegensis peritonitis and invasive disease in a patient on continuous ambulatory peritoneal dialysis.
We report a case of Candida norvegensis invasive disease in an immunosuppressed renal transplant patient on continuous ambulatory peritoneal dialysis. Multiple cultures of peritoneal fluid, blood, and tracheal suction done over a 2-week period were positive for this unusual isolate. Despite treatment with amphotericin B and flucytosine the patient died. This is the first report of C. norvegensis fungemia documented by culture.
Nielsen
H
H
Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
Stenderup
J
J
Bruun
B
B
Ladefoged
J
J
D000328:Adult; D000666:Amphotericin B / Q000008:administration & dosage; D001769:Blood / Q000382:microbiology; D002175:Candida / Q000187:drug effects / Q000302:isolation & purification; D002177:Candidiasis / Q000188:drug therapy / Q000209:etiology*; D004359:Drug Therapy, Combination / Q000008:administration & dosage; D005437:Flucytosine / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D008826:Microbial Sensitivity Tests; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy / Q000209:etiology*
D007166:Immunosuppressive Agents; D000666:Amphotericin B; D005437:Flucytosine